# Xellia Pharmaceuticals ApS, Copenhagen S, Denmark – FDA Inspections

Source: https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57

> Inspection records and compliance data for Xellia Pharmaceuticals ApS in Copenhagen S. 7 FDA inspections on record, 1 Form 483, last inspected October 28, 2021.

---

## Details

- Name: Xellia Pharmaceuticals ApS
- FEI Number: 3002806860
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: Dalslandsgade 11
- City: Copenhagen S
- Country Name: Denmark
- Address: Dalslandsgade 11, Copenhagen S, Denmark
- Country: Denmark

## Related Documents

- [CRL - Xellia Pharmaceuticals ApS - Unknown Date](https://www.keypedia.com/records/crl/xellia-pharmaceuticals-aps/b8fc8c4e-3ce3-4840-99c3-f94fc1bc3803) — source: FDA, date: Invalid Date
- FDA Inspection 1244910 - Xellia Pharmaceuticals ApS - 2021-10-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 28, 2021
- FDA Inspection 1123814 - Xellia Pharmaceuticals ApS - 2019-10-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2019
- [FDA Inspection 1051572 - Xellia Pharmaceuticals ApS - 2018-05-08](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-aps/a6084c75-ea0b-484b-889e-1677b96c612f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 8, 2018
- [FDA Inspection 975111 - Xellia Pharmaceuticals ApS - 2016-03-15](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-aps/61173649-99a4-4003-bcc1-e2f07bd9c518) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2016
- [FDA Inspection 880296 - Xellia Pharmaceuticals ApS - 2014-05-06](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-aps/da13b7fc-f190-486c-953e-8bf6f7dbc112) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 6, 2014
- FDA Inspection 806442 - Xellia Pharmaceuticals ApS - 2012-10-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2012
- FDA Inspection 806442 - Xellia Pharmaceuticals ApS - 2012-10-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2012
- FDA Inspection 651869 - Xellia Pharmaceuticals ApS - 2010-02-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2010

## Related Companies

- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)
- [Taro Pharmaceutical Industries, Ltd.](https://www.keypedia.com/companies/taro-pharmaceutical-industries-ltd/75bff305-a575-43eb-9c35-401fed5479be)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)

## Related Officers

- [Christopher L. Smith](https://www.keypedia.com/people/christopher-l-smith/d1214217-db22-4cd8-bc83-125aa4b565aa)
- [Sumathi Nambiar](https://www.keypedia.com/people/sumathi-nambiar/b43f42b7-24fb-4bce-94c6-5d8ccf88a520)